WebbOn January 30, 2024, the first clinical study of VGN-R09b injection, a gene therapy drug developed by Shanghai Vitalgen BioPharma Co., Ltd. (“Vitalgen BioPharma”) - “an open, dose-escalation early clinical study to evaluate the tolerability, safety and efficacy of intra-striatal injection of VGN-R09b in patients with AADC deficiency” was successfully started … Webb12 apr. 2024 · Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced the company will present one poster concerning Phase 1 clinical results for BAT1006 at the 2024 American Association for Cancer Research ("AACR") Annual Meeting taking place April 14 - April 19, 2024 in Orlando, Florida.
Sanyou Biopharmaceuticals Co., Ltd. LinkedIn
WebbFocusing on the diabetes as the core therapeutic field, Wanbang Biopharma has established a core competitive advantage in R&D, production and sales in the field of “Four High One Anti” (hyperglycemia, hypertension, hyperlipidemia, hyperuricemia and anti-tumor). In 2024, there are 7 products with No.1 domestic market share (IQVIA data) and … Webb亲合力公司是专注于全球创新型抗癌药物开发的临床期生物医药公司,自建有肿瘤微环境特异激活(TMEA,Tumor MicroEnvironment Activated)平台技术(TMEA-SMDC平台 … can glofish sharks live with tetras
Doxorubicin by Shanghai Affinity Biomedical Technology for …
WebbShanghai Pharma Biotherapeutics USA Inc. (SPHBio) is a wholly-owned subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH), one of the largest pharmaceutical … WebbFounded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical … WebbAffinity is a clinical-stage biopharmaceutical company focusing on the development of global anti-cancer drugs. The company's main technology and platforms include tumor … can glofish breed